Effect of tramadol as an adjuvant to ropivacaine in pediatric caudal epidural block

Efficacyof tramadol as an adjuvant to ropivacaine in pediatric caudal epidural block

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190929044924N1

Enrollment

Registered

2019-11-10

Start date

2018-11-22

Completion date

Unknown

Last updated

2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pain control. Other acute postprocedural pain

Interventions

Intervention 1: Intervention group: Patients in first group will receive ropivacaine 0.2% per body weight before extubation. Intervention 2: Intervention group: Patients in second group will receive r

Eligibility

Sex/Gender

All

Age

3 Years to 10 Years

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists (ASA) class I and II Surgery duration 30 minutes to 2 hours No sensitivity to tramadol and rupivacaine

Exclusion criteria

Exclusion criteria: Complicated surgeries (long or bleeding in need of transfusion) Parent do not consent for their child to participate

Design outcomes

Primary

Measure	Time frame
Pain severity. Timepoint: One, 2 and 6 hours after surgery. Method of measurement: Using Modified Children’s Hospital of Eastern Ontario Pain Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza Farahmandrad

Iran University of Medical Sciences

farahmandrad.r@iums.ac.ir+98 21 6435 2326

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026